1Ishii Y, Sawada T, Shimizu A, et al. An experimental sclerosing en- capsulating peritonitis model in mice[ J]. Nephrol Dial Transplant, 16 : 1262 - 1266.
2Di Paolo N, Sacchi G. Atlas of peritoneal histology [ J ]. Perit Dial Int,2000,20 [ Suppl 3 ] : S5 - S96.
3Krediet RT, Lindholm B, Rippe B. Pathophysiology of peritoneal membrane failure[J]. Perit Dial Int,2000,20[ Suppl 4] :S22 - S42.
4Margetts PJ, Bonniaud P. Basic mechanisms and clinical implica- tions of peritoneal fibrosis[ J]. Perit Dial Int,2003 ,23 :530 -541.
5Ersoy R, Celik A, Yilmaz O, et al. The effects of irbesartan and spi- ronolactone in prevention of peritoneal fibrosis in rats[ J]. Perit Di- M Int,2007,27(4) :424 -431.
6Jun Liu,Jinfang Bao,Jing Hao,et al. HSPT0 inhibits high glucose - induced Smad3 activation and attenuates epithelial - to - mesen- chymal transition of peritoneal mesothelial cells[ J]. Mol Med Rep, 2014,10(2) :1089 - 1095.
7Duan WJ, Yu X, Huang XR, et al. Opposing Roles for Smad2 and Smad3 in Peritoneal Fibrosis in Vivo and in Vitro [ J ]. Am J Pathol,2014,184(8) :2275 -2284.
8Amelra LS,Aguilera A,Sanchez- Tomem JA,et al. Epithelial to mes- enchymal transition and peritoneal membrane failure in peritoneal di- alysis patients: pathologic significance and potential therapeutic inter- ventions[ J]. J Am Soc Nephrol,2007,18(7) :2004-2013.
9Lopez - Cabrera M, Aguilera A, Aroeira LS, et al. Ex vivo analysis of dialysis effluent - derived mesothelial cells as an approach to unveiling the mechanism of peritoneal membrane failure [ J ]. Perit Dial Int,2006,26( 1 ) :26 -34.
10Yau - Sheng Tsai, Shih - Yuan Hung, Yi - Che Lee, et al. Shor- ter daily dwelling time in peritoneal dialysis attenuates the epithe- lial - to - mesenehymal transition of mesothelial cells [ J ]. BMC Nephrology,2014,15:35.
